Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

Abstract Background Impaired insight poses a challenge in the treatment of patients with schizophrenia because of its potential to jeopardize therapeutic engagement and medication adherence. This study explored how insight impairment, graded from none to extreme, is related to patient-reported menta...

Full description

Bibliographic Details
Main Authors: Paul H. Lysaker, Peter J. Weiden, Xiaowu Sun, Amy K. O’Sullivan, Joseph P. McEvoy
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Psychiatry
Subjects:
Insight
PANSS
Patient-reported outcome
Neurocognition
Quality of life
Schizophrenia
Online Access:https://doi.org/10.1186/s12888-022-04190-w

Internet

https://doi.org/10.1186/s12888-022-04190-w

Similar Items